These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17061522)

  • 21. Enhancement of immunity to an Escherichia coli vaccine in mice orally inoculated with a fusion gene encoding porcine interleukin 4 and 6.
    Zhang H; Cheng C; Zheng M; Chen JL; Meng MJ; Zhao ZZ; Chen Q; Xie Z; Li JL; Yang Y; Shen Y; Wang HN; Wang ZZ; Gao R
    Vaccine; 2007 Oct; 25(41):7094-101. PubMed ID: 17868957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
    Remer KA; Bartrow M; Roeger B; Moll H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2009 Nov; 299(7):467-78. PubMed ID: 19467927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
    Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intranasal immunization with mucosal complex vaccine protects mice against Toxoplasma gondii].
    Yin GR; Meng XL; Ma GY; Ma XM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Aug; 25(4):290-4. PubMed ID: 18038798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal vaccination approach against mosquito-borne Japanese encephalitis virus.
    Harakuni T; Kohama H; Tadano M; Uechi G; Tsuji N; Matsumoto Y; Miyata T; Tsuboi T; Oku H; Arakawa T
    Jpn J Infect Dis; 2009 Jan; 62(1):37-45. PubMed ID: 19168957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine antibody responses following systemic or mucosal immunization with viable or inactivated Vibrio cholerae.
    Nygren E; Holmgren J; Attridge SR
    Vaccine; 2008 Dec; 26(52):6784-90. PubMed ID: 18951939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
    Isaka M; Zhao Y; Nobusawa E; Nakajima S; Nakajima K; Yasuda Y; Matsui H; Hasegawa T; Maeyama J; Morokuma K; Ohkuma K; Tochikubo K
    Microbiol Immunol; 2008 Feb; 52(2):55-63. PubMed ID: 18380802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant.
    Saito M; Otake S; Ohmura M; Hirasawa M; Takada K; Mega J; Takahashi I; Kiyono H; McGhee JR; Takeda Y; Yamamoto M
    J Infect Dis; 2001 Mar; 183(5):823-6. PubMed ID: 11181162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of different routes of vaccination for eliciting antibody responses in the human stomach.
    Johansson EL; Bergquist C; Edebo A; Johansson C; Svennerholm AM
    Vaccine; 2004 Feb; 22(8):984-90. PubMed ID: 15161075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice.
    Akagi T; Kawamura M; Ueno M; Hiraishi K; Adachi M; Serizawa T; Akashi M; Baba M
    J Med Virol; 2003 Feb; 69(2):163-72. PubMed ID: 12683403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remote glucosyltransferase-microparticle vaccine delivery induces protective immunity in the oral cavity.
    Smith DJ; Lam A; Barnes LA; King WF; Peacock Z; Wise DL; Trantolo DJ; Taubman MA
    Oral Microbiol Immunol; 2003 Aug; 18(4):240-8. PubMed ID: 12823800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responses.
    Nicollier-Jamot B; Ogier A; Piroth L; Pothier P; Kohli E
    Vaccine; 2004 Mar; 22(9-10):1079-86. PubMed ID: 15003634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal vaccination strategies for women.
    Kozlowski PA; Cu-Uvin S; Neutra MR; Flanigan TP
    J Infect Dis; 1999 May; 179 Suppl 3():S493-8. PubMed ID: 10099127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
    Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
    J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant.
    Kende M; Del Giudice G; Rivera N; Hewetson J
    Vaccine; 2006 Mar; 24(12):2213-21. PubMed ID: 16325310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice].
    Huang XG; Xu JQ; Ren L; Qiu C; Zhang N; Liu LX; Wan YM; Peng H; Shao YM
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3109-13. PubMed ID: 17313761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of LOS-specific antibody-secreting cells by ELISPOT assay].
    Jiao XA; Hirano T; Gu XX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):366-9. PubMed ID: 15193241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Kozuka S; Taniguchi T; Matano K; Maeyama J; Komiya T; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 1999 Nov; 18(7-8):743-51. PubMed ID: 10547435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.